Indication
Aspirin-exacerbated Respiratory Disease
3 clinical trials
2 products
2 drugs
Clinical trial
Mechanisms of Dupilumab in AERD - Effects on Aspirin Hypersensitivity Response, With a Focus on Innate Type 2 Inflammatory ResponsesStatus: Recruiting, Estimated PCD: 2025-12-31
Product
AspirinClinical trial
Therapeutic Control of Aspirin-Exacerbated Respiratory DiseaseStatus: Completed, Estimated PCD: 2022-03-30
Product
IfetrobanDrug
VarlilumabClinical trial
Effect of Celecoxib on Postoperative Narcotic Use and Disease Severity in Patients With Aspirin-exacerbated Respiratory Disease and Chronic Rhinosinusitis: a Randomised Controlled TrialStatus: Recruiting, Estimated PCD: 2025-02-01
Drug
Celecoxib